Idoven
PrivateLast Round
Series A
Extension
Sep 5, 2023
Total Funding Raised
$24.51M
Company Overview
Idoven is a health technology company that provides an AI-powered platform for electrocardiogram (ECG) analysis to enable early detection and precision medicine for cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Clinical Trials, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Idoven Comparables
Compare Idoven with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Powerful Medical | 83% | |
| Cardiomatics | 82% | |
| Cordys Analytics | 82% | |
Idoven Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 5, 2023 | ||||
| Grant | Jul 31, 2023 | ||||
| Series A | Jun 21, 2022 | ||||
| Grant | Apr 30, 2022 | ||||
| Seed | May 26, 2021 | ||||
Grant | May 26, 2021 |
Key People
Founding team and executive leadership
Idoven Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| Wayra | Seed, Series A |
| EIT Health | Grant |
| Northzone | Series A, Series A Extension |
| Gasol16 Ventures | Series A Extension |
| Empresa Nacional de Innovación | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2023
Led by Insight Partners and Northzone.
- Jul 31, 2023
$1.65M grant received from EIT Health.
Idoven Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Idoven's valuation, stock price, and market status.